| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $21.5B | $23.4B | $17.4B | $11.3B | $14.0B | $14.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B |
| Operating Income | $0.7B | $0.7B | $0.8B | $1.0B | $0.6B | $0.6B | $0.3B | $0.3B |
| Net Income | $0.5B | $0.5B | $0.6B | $0.7B | $0.4B | $0.4B | $0.0B | $0.1B |
| EPS (Basic) | $24.38 | $24.47 | $25.91 | $28.63 | $15.14 | $13.25 | $1.56 | $2.40 |
| EPS (Diluted) | $24.10 | $24.11 | $25.49 | $28.10 | $14.92 | $13.08 | $1.54 | $2.38 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.7B | $4.5B | $4.3B | $4.1B | $4.0B | $2.7B | $2.7B | $2.4B |
| Current Assets | $0.7B | $0.7B | $0.8B | $0.7B | $0.8B | $0.6B | $0.7B | $0.6B |
| Cash & Equivalents | $0.0B | $0.0B | $0.1B | $0.1B | $0.3B | $0.2B | $0.3B | $0.2B |
| Total Liabilities | $4.1B | $3.7B | $3.5B | $3.5B | $3.2B | $1.9B | $1.9B | $1.6B |
| Current Liabilities | $0.9B | $0.9B | $0.9B | $0.9B | $0.7B | $0.5B | $0.5B | $0.5B |
| Stockholders' Equity | $0.6B | $0.8B | $0.8B | $0.6B | $0.8B | $0.8B | $0.8B | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $0.8B | $0.8B | $1.0B | $0.7B | $0.6B | $0.3B | $0.4B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-0.3B | $-0.3B | $-0.9B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.5B | $-0.4B | $-0.9B | $0.3B | $-0.5B | $-0.0B | $-0.2B |